Hennion & Walsh Asset Management Inc. lessened its position in shares of Elevance Health, Inc. (NYSE:ELV – Free Report) by 51.0% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 1,366 shares of the company’s stock after selling 1,421 shares during the period. Hennion & Walsh Asset Management Inc.’s holdings in Elevance Health were worth $504,000 as of its most recent SEC filing.
A number of other large investors also recently bought and sold shares of the company. Cypress Wealth Services LLC lifted its holdings in Elevance Health by 3.5% during the 3rd quarter. Cypress Wealth Services LLC now owns 679 shares of the company’s stock worth $353,000 after buying an additional 23 shares during the last quarter. Atomi Financial Group Inc. lifted its holdings in Elevance Health by 4.2% during the 3rd quarter. Atomi Financial Group Inc. now owns 615 shares of the company’s stock worth $320,000 after buying an additional 25 shares during the last quarter. Lifeworks Advisors LLC lifted its holdings in Elevance Health by 2.5% during the 3rd quarter. Lifeworks Advisors LLC now owns 1,037 shares of the company’s stock worth $539,000 after buying an additional 25 shares during the last quarter. Catalyst Financial Partners LLC raised its position in shares of Elevance Health by 2.9% during the 3rd quarter. Catalyst Financial Partners LLC now owns 918 shares of the company’s stock worth $477,000 after purchasing an additional 26 shares during the period. Finally, Fullcircle Wealth LLC raised its position in shares of Elevance Health by 1.5% during the 3rd quarter. Fullcircle Wealth LLC now owns 1,743 shares of the company’s stock worth $906,000 after purchasing an additional 26 shares during the period. Institutional investors own 89.24% of the company’s stock.
Elevance Health Stock Performance
Shares of NYSE ELV opened at $384.26 on Tuesday. The stock has a fifty day moving average price of $388.02 and a two-hundred day moving average price of $466.18. The company has a debt-to-equity ratio of 0.56, a quick ratio of 1.50 and a current ratio of 1.50. The firm has a market cap of $89.12 billion, a P/E ratio of 14.01, a PEG ratio of 1.08 and a beta of 0.84. Elevance Health, Inc. has a 1 year low of $362.21 and a 1 year high of $567.26.
Analysts Set New Price Targets
Check Out Our Latest Report on Elevance Health
About Elevance Health
Elevance Health, Inc, together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits.
Featured Stories
- Five stocks we like better than Elevance Health
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- 3 Stocks to Gain From Donald Trump’s External Revenue Service
- 3 Monster Growth Stocks to Buy Now
- AMD: Loop Capital’s Buy Rating Reinforces Investor Confidence
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- Momentum Is Building for Qualcomm to Have a Strong Run in 2025
Receive News & Ratings for Elevance Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elevance Health and related companies with MarketBeat.com's FREE daily email newsletter.